• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中耳胆脂瘤中增殖细胞核抗原的免疫组织化学检测

Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

作者信息

Bujia J, Sudhoff H, Holly A, Hildmann H, Kastenbauer E

机构信息

Department of Otorhinolaryngology, Ludwid-Maximilians-University, Klinikum Grobhadern, Munich, Germany.

出版信息

Eur Arch Otorhinolaryngol. 1996;253(1-2):21-4. doi: 10.1007/BF00176697.

DOI:10.1007/BF00176697
PMID:8932424
Abstract

Cholesteatoma epithelium is characterized by a keratinocyte dysregulation accompanied by destruction of the ossicles and temporal bone. Immunohistochemical methods using antibodies to cell-cycle-related antigens can be used as a means for assessing various aspects of proliferation in cholesteatoma tissue. They also have the important advantage of preserving the spatial orientation of proliferating cells in histological sections. Proliferating cell nuclear antigen (PCNA) is a 36 kDa DNA-delta-polymerase-associated protein that is directly involved in the mechanisms of DNA synthesis. In the present study the expression of PCNA was investigated in formalin-fixed, paraffin-embedded biopsy specimens of cholesteatomas and normal skin. Normal skin revealed nuclear staining in a small number of keratinocytes (PCNA grade, 1.5) located in the basal cell layer. In contrast, an increased number of PCNA-labeled basal and suprabasal epidermal cells (PCNA grade, 9.3) were found in cholesteatoma samples. Our findings indicate that PCNA represents a reliable marker for epithelial proliferation, showing that cholesteatoma epithelium proliferates at a higher rate than normal epidermis. These findings also support the concept of keratinocyte dysregulation in middle ear cholesteatoma.

摘要

胆脂瘤上皮的特征是角质形成细胞失调,并伴有听小骨和颞骨的破坏。使用针对细胞周期相关抗原的抗体的免疫组织化学方法可作为评估胆脂瘤组织增殖各个方面的手段。它们还具有在组织学切片中保留增殖细胞空间取向的重要优势。增殖细胞核抗原(PCNA)是一种36 kDa的与DNAδ聚合酶相关的蛋白质,直接参与DNA合成机制。在本研究中,对胆脂瘤和正常皮肤的福尔马林固定、石蜡包埋活检标本中PCNA的表达进行了研究。正常皮肤在位于基底细胞层的少数角质形成细胞中显示核染色(PCNA分级,1.5)。相比之下,在胆脂瘤样本中发现PCNA标记的基底和基底上层表皮细胞数量增加(PCNA分级,9.3)。我们的研究结果表明,PCNA是上皮增殖的可靠标志物,表明胆脂瘤上皮的增殖速率高于正常表皮。这些发现也支持中耳胆脂瘤中角质形成细胞失调的概念。

相似文献

1
Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.中耳胆脂瘤中增殖细胞核抗原的免疫组织化学检测
Eur Arch Otorhinolaryngol. 1996;253(1-2):21-4. doi: 10.1007/BF00176697.
2
Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
Kaohsiung J Med Sci. 1999 Aug;15(8):468-74.
3
Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
ORL J Otorhinolaryngol Relat Spec. 1996 Jan-Feb;58(1):23-6. doi: 10.1159/000276789.
4
Immunohistochemical study on proliferative activity of experimental cholesteatoma.
Eur Arch Otorhinolaryngol. 2001 Mar;258(3):101-5. doi: 10.1007/s004050100315.
5
A study on epidermal proliferation ability in cholesteatoma.胆脂瘤中表皮增殖能力的研究。
Laryngoscope. 1998 Apr;108(4 Pt 1):537-42. doi: 10.1097/00005537-199804000-00014.
6
Cell proliferation and apoptosis in human middle ear cholesteatoma.人中耳胆脂瘤中的细胞增殖与凋亡
Arch Otolaryngol Head Neck Surg. 1998 Mar;124(3):261-4. doi: 10.1001/archotol.124.3.261.
7
[Expression of calgranulin A and B in middle ear cholesteatoma].
Laryngorhinootologie. 1995 Jan;74(1):33-5. doi: 10.1055/s-2007-997682.
8
[Markers of epidermal proliferation in middle ear cholesteatoma].[中耳胆脂瘤中表皮增殖的标志物]
Otolaryngol Pol. 2003;57(4):505-11.
9
[Expression of 4F2-activation antigen in middle ear cholesteatoma].[4F2激活抗原在中耳胆脂瘤中的表达]
Laryngorhinootologie. 1993 Jul;72(7):324-7. doi: 10.1055/s-2007-997909.
10
[Epithelium-stroma interaction in cholesteatoma of the middle ear].[中耳胆脂瘤中的上皮-基质相互作用]
Laryngorhinootologie. 2001 Jan;80(1):11-7. doi: 10.1055/s-2001-11028.

引用本文的文献

1
Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis.中耳胆脂瘤中的原癌基因突变导致其发病机制。
BMC Med Genomics. 2023 Nov 15;16(1):288. doi: 10.1186/s12920-023-01640-6.
2
Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.获得性胆脂瘤的发病机制与骨吸收:当前认知与未来展望
Clin Exp Otorhinolaryngol. 2016 Dec;9(4):298-308. doi: 10.21053/ceo.2015.01662. Epub 2016 Jul 21.
3
Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

本文引用的文献

1
Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
ORL J Otorhinolaryngol Relat Spec. 1996 Jan-Feb;58(1):23-6. doi: 10.1159/000276789.
2
Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.转化生长因子α对胆脂瘤上皮可能的自分泌生长刺激作用。
Am J Otolaryngol. 1993 Mar-Apr;14(2):82-7. doi: 10.1016/0196-0709(93)90044-8.
3
Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium.
Am J Clin Pathol. 1993 Jul;100(1):22-6. doi: 10.1093/ajcp/100.1.22.
4
大规模蛋白质组学可区分胆脂瘤与周围组织,并鉴定出与发病机制相关的新蛋白质。
PLoS One. 2014 Aug 5;9(8):e104103. doi: 10.1371/journal.pone.0104103. eCollection 2014.
4
Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.定量检测 m-RNA 水平以评估中耳胆脂瘤中环氧化酶-2、诱导型一氧化氮合酶和 12-脂氧合酶基因的表达。
Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1471-5. doi: 10.1007/s00405-013-2614-x. Epub 2013 Jul 6.
5
The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium.HIV 蛋白酶抑制剂洛匹那韦/利托那韦(克力芝)改变了原代牙龈上皮的生长、分化和增殖。
HIV Med. 2011 Mar;12(3):145-56. doi: 10.1111/j.1468-1293.2010.00863.x. Epub 2010 Aug 15.
6
Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium.人类免疫缺陷病毒蛋白酶抑制剂安普那韦对原代牙龈上皮细胞生长和分化的影响。
Antivir Ther. 2010;15(2):253-65. doi: 10.3851/IMP1512.
7
Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.儿童与成人获得性中耳胆脂瘤上皮-基质相互作用的比较分析。
Eur Arch Otorhinolaryngol. 2007 Aug;264(8):841-8. doi: 10.1007/s00405-007-0328-7. Epub 2007 Jun 1.
8
Apoptosis in the pathogenesis of cholesteatoma in adults.
Eur Arch Otorhinolaryngol. 2006 May;263(5):409-13. doi: 10.1007/s00405-005-1026-y. Epub 2005 Dec 24.
9
Etiopathogenesis of cholesteatoma.胆脂瘤的病因发病机制。
Eur Arch Otorhinolaryngol. 2004 Jan;261(1):6-24. doi: 10.1007/s00405-003-0623-x. Epub 2003 Jun 27.
Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
Acta Otolaryngol. 1993 May;113(3):364-8. doi: 10.3109/00016489309135826.
5
Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
Laryngoscope. 1993 Mar;103(3):326-9. doi: 10.1288/00005537-199303000-00015.
6
Inexpensive computer analysis of cell and tissue stainings.
In Vitro Cell Dev Biol Anim. 1994 Sep;30A(9):559-61. doi: 10.1007/BF02631252.
7
Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation.一种细胞核和细胞质多肽的鉴定,其相对比例对细胞增殖速率的变化敏感。
Exp Cell Res. 1981 Dec;136(2):311-9. doi: 10.1016/0014-4827(81)90009-4.
8
Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation.抗人c-myc癌基因产物的抗体:细胞增殖过程中诱导产生的一种进化上保守的蛋白质的证据。
Science. 1984 Aug 17;225(4663):687-93. doi: 10.1126/science.6431612.
9
Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies.人类血液系统恶性肿瘤细胞核仁中的增殖细胞核抗原(PCNA)和人类恶性肿瘤核仁抗原(HMTNA)
Blut. 1983 Mar;46(3):133-41. doi: 10.1007/BF00320271.
10
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.用单克隆抗体Ki-67对一种与细胞增殖相关的人类核抗原进行细胞周期分析。
J Immunol. 1984 Oct;133(4):1710-5.